ARGX argenx SE ADRs

argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:ARGX.

$315.66  -4.14 (-1.30%)
As of 06/22/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  05/18/2017
Outstanding shares:  51,305,610
Average volume:  208,331
Market cap:   $16,323,392,878
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    04016X101
ISIN:        US04016X1019
Sedol:      BDVLM39
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   11.15
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy